Quick Answer
Ascendis Pharma A/S reported Gross Profit of $625.22 million for the year ending 2025.
- Ascendis Pharma A/S showed an increase of +95.8% in Gross Profit from 2024 to 2025.
- This data is from Ascendis Pharma A/S's annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Ascendis Pharma A/S's Gross Profit has grown by 4,574.5%.
- Historical annual values: Fiscal year 2025: $625.22 million | Fiscal year 2024: $319.38 million | Fiscal year 2023: $222.32 million | Fiscal year 2022: $39.04 million | Fiscal year 2021: $4.26 million | Fiscal year 2020: $6.95 million | Fiscal year 2019: $13.38 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: